Displaying episodes 1 - 30 of 40 in total
On this episode host Greg Horne interviews David Rhew, M.D., Global Chief Medical Officer & VP of Healthcare for Microsoft, on the role of technology in health care. Dr. Rhew observed early in his career that evidence-based practices often lead to better health outcomes, but they aren’t adhered to consistently. From there he set out on a digital transformation journey that quickly brought him into health tech and eventually Microsoft. Dr. Rhew and Greg discuss the role of technology in delivering the right information at the right time to improve patient experience and outcomes. According to Dr. Rhew, the next horizon in health care will be around making data more interoperable so that the industry can more effectively and consistently drive actionable insights that improve care. Finally, Dr. Rhew leaves us with his parting thoughts on technology’s capacity to improve health equity and access.
Jennifer Byrne, CEO of contract research organization Javara Research, has a lifelong passion for serving patient populations through clinical research. On this episode, Jennifer shares with Greg the concept of learning health systems that improve health care through research. Javara brings a lot of the traditional advantages that a CRO brings to pharma to health care systems through an integrated research organization approach. The organization’s strategic vision and partnerships are centered around bringing clinical research opportunities to health care systems to meet unmet patient needs while simultaneously partnering with pharma to address the data and scientific needs to clinical trials. The end result of this approach, combined with technology and analytics, is more patient-centric clinical trials that benefit health outcomes for everyone.
The Health Pulse: Modern Consumers Want to Know: How The Pharmaceutical Industry is Influencing Supply Chain Traceability
On this episode, Greg is joined by Grainne Lynch, Senior Manager and Traceability Lead for Accenture. Grainne, an Irish native, helps pharmaceutical companies be compliant with supply chain legislation. She explains to Greg that the pharmaceutical industry is on the forefront of a consumer-led trend demanding the ability to track and trace products end-to-end throughout the supply chain. Now more than ever, consumers want to know a product’s entire history—where it came from, how materials were sourced, where and when it was manufactured, and the process by which it was approved. And, consumers expect companies to be responsible for making good decisions throughout the supply chain. This trend toward greater tracking and tracing is being seen in many industries, and as Grainne explains, life sciences is a natural leader because the industry already has GxP requirements in place. Grianne leaves us with her thoughts on the importance of pharmaceutical traceability to the future growth of the industry as a whole.
Jessica DaMassa is the Executive Producer and Host of video series, What’s the Future, Health?, where she interviews key stakeholders in health tech to uncover unique perspectives on where the industry is headed. On this episode of The Health Pulse, Jessica briefly switches from her usual role as interviewer to guest to share her observations on the trends to watch in health care. The health tech space has seen an unprecedented influx of funding since the early months of the pandemic in 2020. So, where is all this new funding going? Jessica identified three key focus areas – mental health; technology that helps navigate patients into and through the health care system (also know as digital front doors); and AI implementation specifically in the areas of clinical trials and automation of health care administration. On this episode Jessica also shares observations on shifts in the delivery of health care and her best advice for health tech start ups.
Caitlin Donovan is the Global Head of Uber Health. In this role, she’s responsible for figuring out how to fix logistical issues in health care. Coming from a variety of health care executive roles before joining Uber Health, Caitlin observed that all too often what goes wrong in health care isn’t clinical—it’s what happens when patients aren’t in front of their provider. Maybe they don’t have transportation to an appointment, their prescription didn’t arrive or they don’t have access to the food they need. At Uber Health, Caitlin focuses on connecting the dots through data and predictive analytics to solve these challenges. Greg and Caitlin discuss the role of a platform like Uber Health in addressing social determinants and improving population health. Finally, Caitlin shares her thoughts on the biggest health care challenges that Uber Health will tackle next.
The Health Pulse: From basketball to mental health data, Dr. Dawnté Early drives a community-centric approach
Dr. Dawnté Early (she/her) is the Chief of Research and Evaluation for the Mental Health Services Oversight and Accountability Commission in California. Dr. Early supports the Commission’s mission is to transform the mental health system so that everyone who needs care in California receives high-quality and culturally competent care. A big part of her job is bringing together mental health data at the individual level with data from different agencies, including criminal justice, education, quarterly wage, and death and birth data, to identify social determinants of health and uncover disparities. Greg asks about the challenge of overcoming stigma in mental health, and Dr. Early shares that having conversations that normalize and contextualize mental health needs is critical, as is using humanizing language around mental health. The Commission plays role in ensuring these conversations are taking place and that the community is engaged throughout the process. Lastly, Dr. Early shares her vision for the Commission’s role in connecting data to policy to community to outcomes in order to drive more early intervention and prevention in mental health for the betterment of individuals, families and communities.
On this episode, Greg is joined by Herman De Prins, Global CIO of biopharma company UCB. Herman describes UCB’s journey into artificial intelligence (AI), which began with projects aimed at treatments for epilepsy. Herman also shares how UCB promoted data literacy and AI among its staff of more than 8,000 people worldwide, and how the company prioritizes the many projects brought forward by its team of AI enthusiasts. Herman emphasized that there is value in AI across the pharmaceutical value chain, particularly in R&D and commercial. For example, last year UCB used AI to conduct research on potential treatments for COVID-19 and reduced the time typically required for that research from six months to three days. Greg and Herman conclude their chat by discussing the future of AI and Herman’s thoughts on the potential opportunities and pitfalls in a world where AI will increasingly be embedded in technology products all around us.
Peter Muhoro has a front row seat for the ongoing energy transition, so the VP of strategy and technology at Rappahannock Electric Cooperative is the perfect guest to talk with host Sal Gill about what it will require for utilities to start building tomorrow today.
On this episode, Greg talks with Dana Bernson, epidemiologist and Director of Special Analytic Projects at the Massachusetts Department of Public Health, about her work to use data and analytics to guide public health planning and crisis response. Dana shares insights from the department’s initial effort to link data sources across state government to get more contextual information to help address the opioid epidemic. Not surprisingly, one data set often gives us a piece of the puzzle, but linking multiple data sources at the individual level tells a bigger story. Data linkage is critical to understanding social determinants of health to inform effective policy and intervention. This is also true of the COVID-19 pandemic, where Dana’s team is exploring the impact of the pandemic on underserved populations. Finally, Dana shares an update on what has become known as the Public Health Data Warehouse project, which is a research tool that enables analysis of public health priorities and trends, including substance abuse, and maternal and child health. Dana is hopeful that following the coronavirus crisis, public health will receive more consistent and sustainable funding for projects like hers that ultimately support a more complete and proactive approach to health.
Ahad Esmaeilian is helping drive us toward the electricity system of the future. The director of business development for Avangrid, Ahad has earned a Ph.D. from Texas A&M and holds master’s degrees from universities in both the U.S. and his home country of Iran. And while Ahad’s daily focus is to work across the industry to advance clean energy through the interconnection of wind, solar and other utility-scale renewable energy resources, his academic and professional careers have largely focused on digital grids. That means he and host Sal Gill have plenty to talk about in this technical chat around how utilities can build an even greater grid.
The Health Pulse: In life sciences, change is hard but worth it when it comes to digital transformation.
On this episode, Greg chats with SAS EMEA life sciences sales director Jonathan Riches about digital transformation in pharma. Jonathan argues that while buzzword technology like artificial intelligence (AI) and machine learning get a lot of attention, it’s really culture that determines an organization’s success with digital transformation. Why? The life sciences industry is highly regulated by necessity, and many pharmaceutical companies have been around for one hundred or more years. So, while change is challenging for any organization, it is especially challenging for pharma. According to Jonathan, life sciences organizations must back up their analytics evolution with ample training, empowerment around individual growth and C-level commitment to data-driven decision making. For 20 years or more, pharma has been using analytics and statistics to prove the efficacy and safety of drugs in order to obtain regulatory approval. There is now recognition that analytics can glean much deeper insights throughout the pharmaceutical life cycle. This kind of evolution requires significant change-management. Jonathan advises pharmaceutical companies to design data and analytics platforms for the business challenges they need to solve.
Dawn James is a violinist, a geoscientist, a mom and a technology solutions professional. She could even help you understand how fluvial sedimentology works! But those descriptors only scratch the surface of the experience and expertise Dawn brings to her role as the U.S. director of sustainability and environmental services at Microsoft. On this episode of Electrifying AI, Dawn joins host Sal Gill to examine how analytics, artificial intelligence and cloud technologies are playing a role in the ongoing energy transition — and how players in the electricity industry can utilize them to ensure that no one is left behind.
The Reimagine Marketing podcast explores how marketing organizations are re-inventing themselves in the age of the digital consumer. This episode features two of our global co-hosts, Wilson Raj and Steven Hofmans, as they review Season One episodes and guests, explore some of the hot topics facing marketers today and share some of the potential topics we'll unpack during Season Two.
On this episode Major General Elder Granger, M.D. US Army (retired) joins Greg to discuss how lessons learned from military health agencies are inspiring new innovations in public and private health care. For example, how can the private sector adapt the military's proactive screening and treatment of post-traumatic stress disorder (PTSD) to help employees or patients struggling with trauma related to the COVID-19 pandemic, the opioid crisis or other events. Dr. Granger emphasizes the importance of removing the stigma around mental health and improving access to mental health services. Data and enabling technology such as AI will play a pivotal role in the next big innovations in health care, including a future where Dr. Granger predicts we’ll be able to address social determinants of health head on to improve health and health care for all.
Earth Day offers an annual opportunity to reflect on and advance climate action, but this year’s observance brought with it some big news. Among other aims, the Biden Administration announced that the United States will target reducing emissions by 50 percent by 2030, as compared to 2005 levels. Other initiatives were announced around how to help developing countries establish net-zero strategies, how to transform the transportation sector and how to harness the potential of solar, wind and energy storage — among many others. That leaves the electricity industry with plenty to talk about and plenty to do. On this episode of Electrifying AI, Dr. Joe Nyangon, a senior industry consultant for power and utilities innovation here at SAS, joins us to break down the news and examine how the energy and utilities sector can move forward.
In a "socially distant" market, the hotel industry is among the hardest hit. In this episode, Wilson Raj welcomes Clark Twiddy, president of Twiddy & Company, a hospitality and real estate asset management firm located on North Carolina's Outer Banks. Wilson and Clark will examine a set of recovery scenarios for hotels and explore what guests say will make them feel safe when traveling.
Greg chats with SAS customer intelligence (CI) guru Mike Turner about the use of CI in life sciences. While pharma’s customers may look a bit different, it turns out life sciences has a lot to learn about customer engagement from industries like retail, consumer packaged goods and hospitality. Mike and Greg talk about the road ahead for life sciences companies as they shift their sales and marketing programs toward a more strategic approach to customer insights and engagement. Finally, Mike shares his predictions for the future of CI in pharma.
The job of a leader is much more difficult than it once was, according to Bill Boulding, the dean of Duke University’s Fuqua School of Business. Dean Boulding is an expert on leadership — and on this episode of Electrifying AI, he joins host Sal Gill to discuss what leaders in the electricity industry need to focus on for 2021 and beyond. Their conversation spans change management, corporate responsibility, climate change, decarbonization and how the industry can fend off or emerge from crises of leadership and public trust.
In this episode of Reimagine Marketing, Steven Hofmans welcomes Mieke De Ketelaere of IMEC and Ruben Missine of Colruyt Group to discuss artificial intelligence and ethics. Steven, Mieke and Ruben explore the potential risk of AI for consumers and citizens today, how consumers can protect themselves from unethical AI, and how companies should organize to ensure ethical AI approaches.
Greg sits down with Data Sharing and Disclosure Expert Andrew Freeman to discuss his experience at the forefront of the industry initiative to make patient-level data from clinical trials available for research. Andrew shares his views on the availability of results from clinical trials and why it’s important for that data to be available for third-party research. They’ll explore successes of the clinical data transparency movement to date and the challenges and opportunities ahead.
The Smart Electric Power Alliance (SEPA) is a nonprofit organization that boasts almost 1,200 members across electric utilities, corporations and the public sector. The group envisions a carbon-free energy system by 2050, and on this episode of Electrifying AI, SEPA president and CEO Julia Hamm joins host Sal Gill to lay out the path to carbon-free energy as she sees it. Julia and Sal discuss both the short-term and long-term steps needed to reach zero carbon, the role artificial intelligence will play in the push for clean energy, whether we’ve reached “a tipping point” and how Julia earned a 10/10 from Room Rater while working from home.
In this episode of Reimagine Marketing, Wilson Raj and Daniel Newman discuss one of the key goals of our Experience 2030 global research – to identify the buzzwords we’re all hearing and to identify what’s real and what’s not, what’s practical and what’s hype. Wilson and Daniel demystify themes such as AI, the customer journey, real-time analytics and the supposed death of the CMO. Learn about the actionable steps featured in the Experience 2030 playbook and hear several customer examples.
Greg and guest Patrick Homer, SAS commercial pharma industry consultant, discuss the role of analytics in commercialization of pharmaceutical products. From predictive modeling techniques to identify the best prescribers for sales to target, to engagement analytics to improve the quality of online marketing efforts, there are a wealth of opportunities to employ analytics to drive value during the commercial phase. Patrick and Greg will chat about several examples from Patrick’s work, including how analytics helped a major global pharma company transform its COVID-19 webinar campaign into a big success by leveraging insights from engagement analytics.
Much like the electricity industry itself, Electrifying AI is undergoing a transformation. With a new host and a series of energy experts on tap to lend their insight, our second season is getting underway with a bang! Host Sal Gill is joined by journalist David Roberts from Volts to dissect the big trends that will affect the electricity sector in 2021: from the Biden Administration to extreme weather events like what we’ve seen in Texas to the continued digitization of energy, and more. Also new for this season is our Electrifying AI playlist on Spotify. Listen along all season as our guests make their song recommendations, then rock out to their suggestions. Tweet to @TheElectricSal with the song you want to hear on the playlist and we just might include it and send you some Electrifying AI swag to say thanks!
This episode of Reimagine Marketing focuses on the exchange of value between brands and consumers, and what companies can do from a data and marketing perspective to engender trust from their customers. Wilson Raj and Daniel Newman discuss how brands can offer the perfect blend of trust and technology.
Greg and SAS Medical Director Steve Kearney discuss access, attitudes and equity in the global race to administer COVID-19 vaccines. They’ll examine what the early data is telling us about who is getting vaccines. They’ll also look at whether there are disparities in some communities and, if so, what’s driving those disparities. Are all policy and procedural decisions around vaccination data-driven? We wish, but as with any effort this massive, there are gaps in the data and Steve and Greg will discuss where they are and how they impact who is gets vaccinated first.
In this episode of the Reimagine Marketing podcast, Wilson Raj and Daniel Newman discuss how loyalty begins before a customer becomes – or even considers becoming – a customer. Wilson and Daniel showcase the Orlando Magic as an example of implied loyalty (recognition, engagement, transaction loyalty), and share examples of brands who use these loyalty types to infuse loyalty throughout the customer journey.
Data scientist Hiwot Tesfaye joins Greg for a conversation about the use of algorithms in healthcare and how models can introduce bias. They’ll discuss current examples of health care bias, who should be held responsible and how we can do better as an industry in the future.
Reimagine Marketing: Experience 2030 – Immersive Technology > Bridging the Customer Experience Divide
How immersive do people really want their tech to be? Consumers are dipping their toes in immersive technology, whether they even realize it or not. And the opportunities created for brands to engage with their consumers through Snapchat and Instagram filters, heads-up driving displays, and augmented reality shopping experiences.
Behavioral care expert and psychologist Josh Morgan chats with Greg about the role of virtual care in delivery of more equitable and patient centric health care. They’ll explore the potential for telemedicine to help break down barriers, maximize resources, advance holistic outcomes and empower patients.